Mastering the Emotional Side of Oncology Marketing

Posted by Maria Whitman on Thu, Jan 07, 2016

There was a time when clinical evidence—primarily efficacy, tolerability and safety—could be counted on as the most predictable basis for oncology treatment decisions. However, in recent years, my clients and I have seen non-clinical factors become increasingly important to oncologists.


>
Read More

Data Analytics Give Oncology Products Competitive Edge

Posted by Maria Whitman on Tue, Mar 24, 2015

Recent launches have proven that having a great product isn’t enough. To succeed in the oncology market, pharmaceutical and biotech companies must be able to understand performance and opportunities, and explain the difference for increasingly specific patient populations. Data has come a long way, and integrated data analytics is a powerful way to surface and interpret an oncology product’s opportunity amid brutal competition.


>
Read More